| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/18/2001 | WO2001003649A2 Compositions and methods for the treatment of parkinson's disease |
| 01/18/2001 | WO2000062793A3 Pseudomycin antifungal compositions and methods for their use |
| 01/18/2001 | WO2000058488A3 Delivery of functional protein sequences by translocating polypeptides |
| 01/18/2001 | WO2000057918A3 Novel formulations comprising lipid-regulating agents |
| 01/18/2001 | WO2000053213A3 Cyanovirin conjugates, matrix-anchored cyanovirin and anti-cyanovirin antibody, and related compositions and methods of use |
| 01/18/2001 | WO2000034245A3 Crystalline form of benzoquinoline-3-one derivatve as inhibitor of 5-alpha reductase |
| 01/18/2001 | WO2000024360A8 Preparation and use of solidified oils |
| 01/18/2001 | WO2000023565B1 Novel neuropilin/growth factor binding and uses thereof |
| 01/18/2001 | WO1999064049A9 Novel antibacterial agents |
| 01/18/2001 | DE19933670A1 Verwendung von kosmetischen oder dermatologischen Zubereitungen zur Stabilisierung von Ascorbinsäure und/oder Ascorbylverbindungen Use of cosmetic or dermatological preparations for stabilizing ascorbic acid and / or ascorbyl |
| 01/18/2001 | DE19933492A1 Konjugat zur Vermittlung eines zell-, kompartiment- oder membranspezifischen Transports von Wirksubstanzen Conjugate to the presentation of cell-, or compartment-specific membrane transport of active substances |
| 01/18/2001 | DE19932157A1 Verfahren zur schonenden Herstellung von hochfeinen Mikropartikeln und Nanopartikeln Method for the gentle production of ultrafine microparticles and nanoparticles |
| 01/18/2001 | DE19932076A1 Vernetzerfreie Zubereitungen Vernetzerfreie preparations |
| 01/18/2001 | DE19932075A1 Vernetzerfreie Zubereitungen Vernetzerfreie preparations |
| 01/18/2001 | CA2680437A1 Peptides that lower blood glucose levels |
| 01/18/2001 | CA2416233A1 Compositions and methods for the treatment of parkinson's disease |
| 01/18/2001 | CA2378949A1 Growth hormone formulations |
| 01/18/2001 | CA2378768A1 Active substance-containing multilayer film of hydrophilic polymers crosslinked in situ |
| 01/18/2001 | CA2378451A1 Anti-idiotypic antibodies of fibroblast growth factors and their use as medicines |
| 01/18/2001 | CA2377902A1 Novel prodrugs for antimicrobial amidines |
| 01/18/2001 | CA2377677A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 01/18/2001 | CA2375992A1 Method for controlled production of ultrafine microparticles and nanoparticles |
| 01/18/2001 | CA2375640A1 Dry powder compositions |
| 01/18/2001 | CA2375616A1 Improvements in and relating to delivery capsules |
| 01/18/2001 | CA2374395A1 Preservatives for perishable preparations, in particular for cosmetic and pharmaceutical preparations |
| 01/18/2001 | CA2341035A1 Pulmonary delivery of liposomal-encapsulated cannabinoids |
| 01/18/2001 | CA2340757A1 Delivery of liposomal-encapsulated antioxidants and applications thereof |
| 01/17/2001 | EP1069150A2 Oil-in-oil and three-phase emulsions |
| 01/17/2001 | EP1069142A1 Water soluble polymers and their use in cosmetic and pharmaceutic products |
| 01/17/2001 | EP1068867A2 Pharmaceutical tablet comprising an NSAID and misoprostol |
| 01/17/2001 | EP1068854A1 Solid form composition comprising an oil and a specific gelling agent, process for cosmetic treatment and use of this compound |
| 01/17/2001 | EP1068338A2 Enhanced prodrug activation |
| 01/17/2001 | EP1068332A2 Recombinant anti-tumor rnase |
| 01/17/2001 | EP1068306A1 Pentaerythritol lipid derivatives |
| 01/17/2001 | EP1068257A1 Production of microparticles |
| 01/17/2001 | EP1068242A2 Immune response modulator alpha-2 macroglobulin complex |
| 01/17/2001 | EP1068241A1 Antibody variants and fragments thereof |
| 01/17/2001 | EP1068240A1 Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and uses |
| 01/17/2001 | EP1068226A1 Lipopeptides inducing t lymphocytic cytotoxicity bearing at least one auxiliary t epitope, and uses for vaccination |
| 01/17/2001 | EP1068225A2 New compounds for dna-transfection |
| 01/17/2001 | EP1068188A1 Novel nucleic acid transfer agents, compositions containing same and uses |
| 01/17/2001 | EP1067972A1 Multicomponent complex for use with a substrate |
| 01/17/2001 | EP1067971A1 Inorganic material for radioactive drug delivery |
| 01/17/2001 | EP1067967A1 A drug composition containing sodium pravastatin |
| 01/17/2001 | EP1067966A1 OPHTHALMIC COMPOSITION COMPRISING A $g(b)-BLOCKER |
| 01/17/2001 | EP1067943A1 Process of making an aqueous calcium carbonate suspension |
| 01/17/2001 | EP1067942A1 High-energy cyclodextrin complexes |
| 01/17/2001 | EP1067937A1 Sustained-release composition containing cefaclor |
| 01/17/2001 | EP1067936A1 Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants |
| 01/17/2001 | EP1067927A1 Antioxidant stabilizer system for pharmaceutical formulations |
| 01/17/2001 | EP1067918A1 Stable dosage forms of fluoxetine and its enantiomers |
| 01/17/2001 | EP1067916A2 Method for producing transdermal therapeutic systems by using basic alkali metal salts for converting active agent salts into free bases |
| 01/17/2001 | EP1067915A2 Device for the transdermal delivery of diclofenac |
| 01/17/2001 | EP1067914A2 Composition and method of preparing microparticles of water-insoluble substances |
| 01/17/2001 | EP1067912A1 Modified starch coating |
| 01/17/2001 | EP1067911A1 Hydrogel compositions useful for the sustained release of macromolecules and methods of making same |
| 01/17/2001 | EP1067910A1 Controlled release composition |
| 01/17/2001 | EP1067909A1 Cationic lipid formulation delivering nucleic acid to peritoneal tumors |
| 01/17/2001 | EP1067908A1 Anticancer compositions |
| 01/17/2001 | EP1067907A1 Ocular irrigating solution |
| 01/17/2001 | EP1067905A1 Fizzy formulations |
| 01/17/2001 | EP1067904A1 Solid, quick dissolving cetirizine formulations |
| 01/17/2001 | EP1067898A1 Artificial nail compositions and related methods |
| 01/17/2001 | EP1067897A1 An acidified composition for topical treatment of nail and skin conditions |
| 01/17/2001 | EP1067896A4 Ascorbyl-phosphoryl-cholesterol |
| 01/17/2001 | EP1067896A1 Ascorbyl-phosphoryl-cholesterol |
| 01/17/2001 | EP0771216B1 Methods and compositions for the specific coagulation of tumoral vasculature |
| 01/17/2001 | EP0732912B1 Cosmetic and/or pharmaceutical preparations with improved skin feel |
| 01/17/2001 | EP0626855B1 Health and beauty aid compositions |
| 01/17/2001 | CN1280611A Method and compositions for binding hematopoietic stem cells |
| 01/17/2001 | CN1280511A A one dose syringe, comprising a freeze-dried protein composition, for administering of a volume less than 0.5ml |
| 01/17/2001 | CN1280507A Minoxidil-containing liquid preparation composition |
| 01/17/2001 | CN1280506A Oral Preparation |
| 01/17/2001 | CN1280501A Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 01/17/2001 | CN1280498A Use of phospholipid complexes of extracts of i(vitis vinifera) as anti-atherosclerotic agent |
| 01/17/2001 | CN1280495A Use of a mixture of a diol and an alpha-hydroxy acid for treatment of hyperkeratotic skin diseases |
| 01/17/2001 | CN1280493A Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances |
| 01/17/2001 | CN1280492A Porous hydroxyapatite particles as carriers for drug substances |
| 01/17/2001 | CN1280490A Peptide/lipid complex formation by co-lyophilization |
| 01/17/2001 | CN1280489A Suppository composition |
| 01/17/2001 | CN1280483A Site-specitic preparation of polyethylene glycol-GRF conjujates |
| 01/17/2001 | CN1280137A Erythrocyte-stimulating factor coupling |
| 01/17/2001 | CN1060647C Iron-supplementing preparation capable of permeating skin and preparation method thereof |
| 01/16/2001 | US6174999 Mixing polysaccharides, a nucleophile, and an activating agent like benzotriazole-1-yloxytris(dimethylamino) phosphonium hexafluorophosphate in an aqueous solution |
| 01/16/2001 | US6174873 Oral administration of adenosine analogs |
| 01/16/2001 | US6174858 Conjugates useful in the treatment of prostate cancer |
| 01/16/2001 | US6174856 Stabilized insulin compositions |
| 01/16/2001 | US6174723 Cocaine derivative, protein conjugate thereof, monoclonal antibody producing cell line, method for preparing the cell line and monoclonal antibody |
| 01/16/2001 | US6174687 Methods of identifying lung homing molecules using membrane dipeptidase |
| 01/16/2001 | US6174548 Pharmaceutical composition of omeprazole for oral administration which consists essentially of a tabletted core and coating layer |
| 01/16/2001 | US6174543 Antidiabetic external skin application composition |
| 01/16/2001 | US6174540 Comprising therepeutic agent selected from insecticides, acaricides, parasiticides, growth enhancers, and nasids; hydrogenated castor oil; hydrophobic carrier |
| 01/16/2001 | US6174539 Localized use of nitric oxide adducts to prevent internal tissue damage |
| 01/16/2001 | US6174530 Homogeneous polyoxime compositions and their preparation by parallel assembly |
| 01/16/2001 | US6174529 Oral therapy for the treatment of allergies and method of manufacture |
| 01/16/2001 | US6174513 A storage stable therapeutic composition comprising one or more surfactants to prevent radiolysis during storage; producing therapeutic effects on targeted tissues |
| 01/16/2001 | CA2052615C Pharmaceutical composition in gel form in a dispensing package |
| 01/16/2001 | CA2010800C Protein labelling |
| 01/15/2001 | CA2314538A1 Composition in solid form including an oil and special gelling compound, cosmetic treatment process and use of said compound |
| 01/14/2001 | CA2277407A1 Pharmaceutical tablet comprising an nsaid and misoprostol |